Showing 121 - 130 of 654,054
Persistent link: https://www.econbiz.de/10005125982
The increasing resistance of harmful biological organisms (bacteria, parasites, and pests) to selection pressure from the widespread use of control agents such as antibiotics, antimalarials, and pesticides is a serious problem in both medicine and agriculture. Modeling resistance —or,...
Persistent link: https://www.econbiz.de/10005442314
Hace un año, un grupo heterogéneo de investigadores del Centro de Investigación de la Universidad del Pacífico (CIUP) inició un esfuerzo colectivo para pensar en el futuro de nuestra economía y sociedad más allá del corto plazo. El trabajo que presentamos a continuación resume algunas...
Persistent link: https://www.econbiz.de/10010735920
The 2010 Report continues the tradition of pushing the frontiers of development thinking. For the first time since 1990, the Report looks back rigorously at the past several decades and identifies often surprising trends and patterns with important lessons for the future. These varied pathways...
Persistent link: https://www.econbiz.de/10008837640
More than forty states worldwide currently pursue explicit political strategies to expand and promote their bioeconomies. This paper assesses these strategies in the context of the global Sustainable Development Goals (SDGs). Our theoretical framework differentiates between four pathways of...
Persistent link: https://www.econbiz.de/10011879079
More than forty states worldwide currently pursue explicit political strategies to expand and promote their bioeconomies. This paper assesses these strategies in the context of the global Sustainable Development Goals (SDGs). Our theoretical framework differentiates between four pathways of...
Persistent link: https://www.econbiz.de/10014112589
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Persistent link: https://www.econbiz.de/10012435267
Persistent link: https://www.econbiz.de/10011958562